WASH

Does infection data add evidence to understanding of trachoma prevalence in low endemic areas?

To investigate the utility of an antibody test as a tool for surveillance during the elimination phase of trachoma programmes

Countries: Tanzania
Diseases: Trachoma

Mapping schistosomiasis and soil-transmitted helminthiasis in Namibia

Assessing treatment needs for school-aged children and assisting Ministry of Health to develop an effective control programme

Countries: Namibia

Drug formulation for pre-school children

Understanding the basic pharmacology of praziquantel tailored to paediatric setting and developing a treatment access plan for this age class

Countries:

COUNTDOWN Calling

Helping increase and sustain the scale-up of preventive chemotherapy campaigns in West and Central Africa

Countries:

Interventions in Persistent Hot-Spots in Tanzania

How do villages which do not show substantial decreases in the prevalence of schistosomiasis despite repeated, high coverage mass drug administration (persistent hot-spot villages) differ from villages which show substantial decrease in prevalence across various factors (declining prevalence villages)?

Countries: Tanzania
Diseases: Schistosomiasis

The Impact of WASH on Re-infection with STH

Study the impact of WASH on Trachoma by adding an STH intervention and post-treatment evaluation. WASH intervention and control communities will be treated with albendazole and STH burden will be assessed pre-treatment and at annual intervals thereafter.

Countries: Ethiopia

Monitor STH in PSAC and WCBA following cessation of LF MDA (Tanzania)

Monitor recrudescence of STH after TAS to improve planning of STH programs and more effective use of STH drugs.

Countries: Tanzania

Monitor STH in PSAC and WCBA following cessation of LF MDA (Togo)

Monitor recrudescence of STH after TAS to improve planning of STH programs and more effective use of STH drugs.

Countries: Togo

Alternative approaches to coverage surveys (Honduras)

Develop a program evaluation tool to permit program managers to effectively assess coverage and compliance. This study will focus on assessing MDA coverage for lymphatic filariasis by comparing the cost, time and feasibility of the EPI approach (n=480), LQAS design (n=95) and probability sampling alternatives (n=480).

Preliminary study findings:

  • All three survey methods were feasible for the teams to implement and cost <$5,000.
  • Preschool deworming coverage, provided through the community-based MDA, was <60%.
  • The main reason for refusing the medication was that the child had recently been dewormed.
  • Approximately 80% of preschool children surveyed received at least one dose of unprogrammed deworming in the past 12 months.
  • The main sources of unprogrammed deworming were health centers, local pharmacies, and bodegas.
Countries: Honduras

Pages